Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive

This study has been completed.
Sponsor:
Collaborator:
Biogen
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT00000721
First received: November 2, 1999
Last updated: May 17, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 1991
  Estimated Primary Completion Date: No date given